A detailed history of Private Advisor Group, LLC transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Private Advisor Group, LLC holds 31,427 shares of RXRX stock, worth $209,932. This represents 0.0% of its overall portfolio holdings.

Number of Shares
31,427
Previous 15,419 103.82%
Holding current value
$209,932
Previous $101,000 109.9%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 31, 2025

BUY
$5.7 - $8.27 $91,245 - $132,386
16,008 Added 103.82%
31,427 $212,000
Q3 2024

Oct 22, 2024

BUY
$5.92 - $8.6 $20,317 - $29,515
3,432 Added 28.63%
15,419 $101,000
Q2 2024

Aug 05, 2024

BUY
$7.35 - $10.05 $88,104 - $120,469
11,987 New
11,987 $89,000
Q3 2023

Nov 02, 2023

BUY
$6.59 - $15.86 $68,048 - $163,770
10,326 New
10,326 $78,000

Others Institutions Holding RXRX

About RECURSION PHARMACEUTICALS, INC.


  • Ticker RXRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 180,480,000
  • Market Cap $1.21B
  • Description
  • Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...
More about RXRX
Track This Portfolio

Track Private Advisor Group, LLC Portfolio

Follow Private Advisor Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Advisor Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Advisor Group, LLC with notifications on news.